Varun Dwaraka is a bioinformatics researcher specializing in epigenetics and machine learning. He leads a team at TruDiagnostic which implements machine learning methods to identify epigenetic biomarkers, and generate predictive algorithms, which help understand the molecular biology of aging. These tools are then used to investigate associations of aging to an individuals disease, and overall mortality, risk. His work has been published in numerous peerreviewed publications, and have been patented. His work has been featured in periodicals (e.g., Forbes), documentaries (e.g., HBO and Netflix), and podcasts (e.g., Alldus International). In 2020, Dr. Dwaraka was elected as a full member to the Sigma Xi, The Scientific Research Honor Society, and served as a 2023 Foresight Fellow in Biotechnology and Health Expansion, awarded by the Foresight Institute. He also serves on Scientific Advisory Boards for various entities (e.g., SRW Labs) to which he offers insight into the application and interpretation of epigenetic age biomarkers.
Developing the most predictive and clinically informative biological clock
Increasing biological age is the biggest risk factor for chronic disease and death; therefore, accurate prediction of biological age is imperative to understand how therapeutics affect the aging process. This presentation will showcase our efforts using MLAI on multiomics to develop biological age predictors exhibiting significant clinical utility, which revolutionize patient care and longevity research.
Genomic Profiling Showcase:
TruDiagnostic is a revolutionary epigenetics company which seeks to help people to better understand their aging and longevity health by accessing insight from their epigenome. TruDiagnostic also research & develop epigenetic analysis methods in the effort to create new methylation-based medical diagnostic tools.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.